Measurement of changes in serum-based inflammatory indicators to monitor response to nivolumab monotherapy in advanced gastric cancer: a multicenter retrospective study

Measurement of changes in serum-based inflammatory indicators to monitor response to nivolumab monotherapy in advanced gastric cancer: a multicenter retrospective study

Abstract Background Nonresectable gastric cancer develops rapidly; thus, monitoring disease progression especially in patients receiving nivolumab as late-line therapy is important. Biomarkers may facilitate the evaluation of nivolumab treatment response. Herein, we assessed the utility of serum-bas...

Full description

Bibliographic Details
Main Authors: Michiko Inukai, Tomohiko Nishi, Hiroshi Matsuoka, Kazuhiro Matsuo, Kazumitsu Suzuki, Akiko Serizawa, Shingo Akimoto, Masaya Nakauchi, Tsuyoshi Tanaka, Kenji Kikuchi, Susumu Shibasaki, Ichiro Uyama, Koichi Suda
Format: Article
Language:English
Published: BMC 2024-09-01
Series:BMC Cancer
Subjects:
Nivolumab
Biomarkers
Stomach neoplasms
Chemotherapy
Blood platelets
Lymphocytes
Online Access:https://doi.org/10.1186/s12885-024-12813-6

Internet

https://doi.org/10.1186/s12885-024-12813-6

Similar Items